Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverley J Paterson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Vaccine|October 5, 2014
The case for ILI surveillanceBeverley J Paterson, David N Durrheim
Lancet (London, England)|March 15, 2016
The Harvard-LSHTM panel on the global response to Ebola reportBeverley J Paterson, David N Durrheim
The Lancet. Infectious Diseases|August 29, 2014
Measurement of surveillance signal response effectivenessBeverley J Paterson, David N Durrheim
Journal of Epidemiology and Global Health|July 17, 2013
The remarkable adaptability of syndromic surveillance to meet public health needsBeverley J Paterson, David N Durrheim
Communicable Diseases Intelligence Quarterly Report|October 31, 2013
Review of Australia's polio surveillanceBeverley J Paterson, David N Durrheim
Travel Medicine and Infectious Disease|March 27, 2016
Zika virus from a Pacific perspective: What are the risks to Australians?Kathryn A Taylor, Beverley J Paterson
The Lancet. Planetary Health|February 12, 2022
Wastewater surveillance: an effective and adaptable surveillance tool in settings with a low prevalence of COVID-19Beverley J Paterson, David N Durrheim
The New England Journal of Medicine|August 31, 2012
Guillain-Barré syndromeBeverley J Paterson, David N Durrheim
Influenza and Other Respiratory Viruses|March 7, 2013
Pandemic response in low-resource settings requires effective syndromic surveillanceBeverley J Paterson, David N Durrheim, Kate Hardie
Communicable Diseases Intelligence Quarterly Report|September 16, 2014
Australia's polio riskNicolee Martin, Beverley J Paterson, David N Durrheim
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Vaccine|October 5, 2014
The case for ILI surveillanceBeverley J Paterson, David N Durrheim
Lancet (London, England)|March 15, 2016
The Harvard-LSHTM panel on the global response to Ebola reportBeverley J Paterson, David N Durrheim
The Lancet. Infectious Diseases|August 29, 2014
Measurement of surveillance signal response effectivenessBeverley J Paterson, David N Durrheim
Journal of Epidemiology and Global Health|July 17, 2013
The remarkable adaptability of syndromic surveillance to meet public health needsBeverley J Paterson, David N Durrheim
Communicable Diseases Intelligence Quarterly Report|October 31, 2013
Review of Australia's polio surveillanceBeverley J Paterson, David N Durrheim
Travel Medicine and Infectious Disease|March 27, 2016
Zika virus from a Pacific perspective: What are the risks to Australians?Kathryn A Taylor, Beverley J Paterson
The Lancet. Planetary Health|February 12, 2022
Wastewater surveillance: an effective and adaptable surveillance tool in settings with a low prevalence of COVID-19Beverley J Paterson, David N Durrheim
The New England Journal of Medicine|August 31, 2012
Guillain-Barré syndromeBeverley J Paterson, David N Durrheim
Influenza and Other Respiratory Viruses|March 7, 2013
Pandemic response in low-resource settings requires effective syndromic surveillanceBeverley J Paterson, David N Durrheim, Kate Hardie
Communicable Diseases Intelligence Quarterly Report|September 16, 2014
Australia's polio riskNicolee Martin, Beverley J Paterson, David N Durrheim
Pageof 2